Top Markets
Coin of the day
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Clasificación en acciones #18601
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Precio por acción
$2.88
Capitalización bursátil
$192.66M
Cambio (1 día)
-0.55%
Cambio (1 año)
-59.61%
País
TW
Comercio Alar Pharmaceuticals Inc. (6785)

Categoría

Ratio P/S de Alar Pharmaceuticals Inc. (6785)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Alar Pharmaceuticals Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Alar Pharmaceuticals Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras